Replimune (REPL) Share-based Compensation (2017 - 2026)

Replimune (REPL) reported Share-based Compensation of $8.1 million for Q1 2026, down 1.87% on a YoY basis from $8.3 million in Q1 2025, and up 15.3% sequentially from $7.0 million in Q4 2025.

Replimune (REPL) Share-based Compensation (2017 - 2026) Analysis & Trends

Replimune (REPL) has 10 years of Share-based Compensation data on file, last reported at $8.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 1.87% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $32.3 million (down 7.91% YoY), and the FY2026 full-year result was $32.3 million, down 7.91% from the prior year.
  • Share-based Compensation rose to $8.1 million in Q1 2026, from $7.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $9.5 million in Q2 2024 to a low of $5.8 million in Q1 2022.
  • A 5-year average of $8.0 million and a median of $8.2 million in 2023 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation jumped 66.27% in 2022 and dropped 18.43% in 2025, its largest moves.
  • Tracing REPL's Share-based Compensation over 5 years: stood at $7.0 million in 2022, then grew by 17.33% to $8.2 million in 2023, then gained by 4.84% to $8.6 million in 2024, then retreated by 18.43% to $7.0 million in 2025, then rose by 15.3% to $8.1 million in 2026.
  • Business Quant data shows REPL's Share-based Compensation at $8.1 million in Q1 2026, $7.0 million in Q4 2025, and $8.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Replimune 970.73 Mn 970.73 Mn - 8.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.13 Mn
Mar 31, 2026 8.13 Mn
Dec 31, 2025 7.05 Mn
Dec 31, 2025 7.05 Mn
Sep 30, 2025 8.34 Mn
Sep 30, 2025 8.34 Mn
Jun 30, 2025 8.76 Mn
Jun 30, 2025 8.76 Mn
Mar 31, 2025 8.28 Mn
Mar 31, 2025 8.28 Mn
Dec 31, 2024 8.64 Mn
Dec 31, 2024 8.64 Mn
Sep 30, 2024 8.65 Mn
Sep 30, 2024 8.65 Mn
Jun 30, 2024 9.48 Mn
Jun 30, 2024 9.48 Mn
Mar 31, 2024 7.92 Mn
Mar 31, 2024 7.92 Mn
Dec 31, 2023 8.24 Mn
Dec 31, 2023 8.24 Mn